A review of Friday done on a Saturday and posted Sunday 🙄 I apologize. this started out to be a quick overview but turned into much, much more 😅. This is written over multiple sessions, so the style changes. Hang in there it may be worth the read 🤷 this turned out longer than I had planned, but my best ones often do 😉 Alright... I know, a complete bother. this iam guy 🔴 filling up Moomoo with his memes and junk 😆 so, what's more junk 🤷 I'll give this a go and see if moo all lik...
tpearly :
Much love kind sir! Thank you for your thorough insights, poetry, images, and chart patients. I took a lot of screenshots to study on the desktop as I'm reading this on mobile. Like many others, we look forward to your insights. Christ bless you.
Despite recent court losses, Bayer insists Roundup and its key ingredient, glyphosate, are safe, a claim backed by regulatory support. This new victory could strengthen Bayer's footing in continuous and future Roundup disputes.
POSSIBLE TRADE IDEA? $モデルナ(MRNA.US)$ This is basically how I make my short term plays. If the price of MRNA can bounce off support then I will be looking for a long position. If MRNA breaks down below support and a lot of seller step in then I will be looking for a short position. I am judging the entry point of my trade off of the price channel that MRNA has been traveling within for several weeks. It is a very short-term price cha...
SpyderCallスレ主Mike Hunt:
nice!!!! I remember SIGA started running soon as they had a headline about monkey pox vaccines and whatnot. I'm definitely keeping these on watch for next week. they could be finished running but it's always nice to keep watch
Mike HuntSpyderCallスレ主:
The fact they had solid earnings this week with no movement is typical sometimes of these large caps. They make the appropriate gains over the next week or 2 following a bear rather than on that earnings day sometimes
Gainers: •$アクサム・セラピューティクス(AXSM.US)$+39.1% (received from FDA proposed labeling for the its AXS-05 product candidate with respect to its New Drug Application for AXS-05 for the treatment of major depressive disorder) •$カプリコー・セラピューティクス(CAPR.US)$+4% (announces statistically significant clinical benefits in skeletal muscle function in non-ambulant duchenne muscular dystrophy patients treated with CAP-1002 in HOPE-2 Open L...
Taurus27 : Thank you for taking the efforts to share with us your thoughts. Do rest well .
101633546 : thanks for the UEC update!
TinkerB3ll : Rest well and enjoy the rest of the Sunday evening.
SL99 : 学到了很多,虽然对于图还是不太懂但是会努力慢慢学会看懂,非常感谢你的分享和所付出的时间
tpearly : Much love kind sir! Thank you for your thorough insights, poetry, images, and chart patients. I took a lot of screenshots to study on the desktop as I'm reading this on mobile. Like many others, we look forward to your insights. Christ bless you.
もっとコメントを見る...